Top Companies in North America Measles, Mumps and Rubella Vaccines Market with Market Size | Manufacturers 2025

Top Companies in North America Measles, Mumps and Rubella Vaccines Market with Market Size

The North America Measles, Mumps and Rubella Vaccines Market has witnessed significant growth as leading companies represent the backbone of the measles, mumps, and rubella vaccine market in North America, with robust innovations and a commitment to advancing public health. Apart from this, these companies are at the forefront of innovating in the field of vaccines and immunology, employing cutting-edge technologies and research methodologies to combat infectious diseases. Additionally, addressing global vaccine needs, including MMR. With their dedication to research and development, contributing to advancements in the field of vaccines and immunology.

These companies have played a pivotal role in focusing on public health threats and infectious diseases. Their commitment to developing, manufacturing, and distributing vaccines has positioned them as a vital contributor to the immunization landscape. Together, these companies represent the backbone of the North America MMR vaccines market, offering robust innovations and a steadfast commitment to advancing public health. With their cutting-edge research, development capabilities, and comprehensive approach to addressing global vaccine needs, they play a significant role in preventing the spread of measles, mumps, and rubella in North America. As per 6Wresearch, the North America Measles, Mumps and Rubella Vaccines Market is projected to grow at a significant CAGR of 5.8% from 2025-2031F.

List of Leading Companies in the North America Measles, Mumps and Rubella Vaccines Market

1. Merck & Co., Inc.

Merck is a leading pharmaceutical company known for producing priority vaccines like M-M-R® II, a highly effective combination vaccine for measles, mumps, and rubella. They focus on delivering innovative healthcare solutions globally, with a strong emphasis on vaccine development and immunization programs.

2. GlaxoSmithKline (GSK)

GSK focuses on innovative medicines, vaccines, and consumer healthcare. The company plays a significant role in the MMR vaccines market, with a portfolio aimed at improving global immunization, including research into newer vaccine technologies.

3. Sanofi Pasteur

Sanofi Pasteur is a key player in the vaccines market, known for its commitment to public health. With a strong R&D arm, it focuses on developing and distributing vaccines that address infectious diseases, including measles, mumps, and rubella.

4. Pfizer Inc.

Pfizer is a global pharmaceutical leader with diverse vaccine offerings. While their primary focus includes innovative vaccines for various diseases, their capabilities in production and R&D make them a significant contributor to the immunization ecosystem.

5. Moderna, Inc.

Moderna is recognized for pioneering mRNA-based vaccine technology. While currently focused on COVID-19 vaccines, the company's state-of-the-art platform positions them as a potential innovator in the MMR vaccine landscape.

6. Johnson & Johnson (Janssen Pharmaceuticals)

Janssen Pharmaceuticals, a division of Johnson & Johnson, conducts significant R&D in vaccines and infectious diseases. Their experience in global healthcare solutions contributes to advancements in the vaccine market.

7. Novavax, Inc.

Novavax specializes in next-generation vaccines, particularly those targeting emerging infectious diseases. With innovative vaccine platforms, they remain a contender in expanding MMR vaccine technology.

8. Dynavax Technologies Corporation

Dynavax focuses on leveraging immuno-stimulatory technology to develop effective vaccines. While best known for hepatitis vaccines, their growing portfolio includes work in multi-disease prevention.

9. AstraZeneca

AstraZeneca's contributions to vaccines and immunology include cutting-edge research and development. Their advanced biologics division positions them as a key player in addressing global vaccine needs, including MMR.

10. Emergent BioSolutions

Emergent BioSolutions focuses on public health threats, including infectious diseases. Their efforts in developing, manufacturing, and distributing vaccines make them a vital contributor to the immunization landscape.

Frequently Asked Questions About the Market Study (FAQs):